WO2007034627A1 - 動物用飼料添加剤 - Google Patents
動物用飼料添加剤 Download PDFInfo
- Publication number
- WO2007034627A1 WO2007034627A1 PCT/JP2006/315211 JP2006315211W WO2007034627A1 WO 2007034627 A1 WO2007034627 A1 WO 2007034627A1 JP 2006315211 W JP2006315211 W JP 2006315211W WO 2007034627 A1 WO2007034627 A1 WO 2007034627A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aspergillus
- strain
- aok
- culture
- feed additive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Definitions
- the present invention relates to an animal feed additive containing Aspergillus sp. Having an ability to produce an acidic enzyme.
- Patent Documents 1 and 2 In recent years, in order to improve the balance of intestinal flora and suppress the growth of pathogenic bacteria in the intestine, a technique using probiotics has attracted attention (Patent Documents 1 and 2). However, lactic acid bacteria and bifidobacteria are strong against microorganisms among bile acids, except for bacteria collectively called coliforms that die at 0.3% deoxycholic acid concentration or die most at pH 4 or lower. !, Many species cannot survive in the presence of antibacterial deoxycholate. Therefore, there is a demand for strains that do not die in the digestive tract of animals and that have beneficial effects on the host.
- Patent Document 4 Japanese Patent Publication No. 6-319464
- Patent Document 6 Japanese Patent Application Laid-Open No. 2002-238466
- Non-Patent Document 2 Harry E. Morton, Walter Kocholaty, Renate Junowicz- Kocholaty, and Albert Kelner (1945) J. Bacteriol 50, 579—584
- An object of the present invention is to provide a safe and simple means for assisting an animal's digestive activity and increasing feed efficiency. Specifically, by using bacteria that can grow in the digestive tract of animals, it is possible to prevent and treat infectious diseases by suppressing the growth of pathogenic fungi in the intestines of animals, thereby increasing the weight of animals. It is an object to provide means for realizing.
- a feed additive for animals comprising a culture containing at least one bacterium selected from Aspergillus niger and Aspergillus oryzae, and an acid enzyme produced by these bacterium.
- the Aspergillus oryzae is the Aspergillus oryzae IK-05074 strain (FE RM BP-10622) or a mutant strain of the strain having the ability to produce the same acidic enzyme (1) or (2) Animal feed additive as described in 1.
- microorganism according to any one of (1) to (4), characterized in that it has antibacterial activity against pathogenic bacteria causing enteric infections in animals and protozoan activity against Z or kokushijium. Animal feed additive.
- Aspergillus tamari is a type of imperfect fungi found in soil, koji, food, and the like, and is used for brewing soy sauce and miso.
- the animal feed additive of the present invention has an ability to produce at least one acidic enzyme described in detail below, preferably acidic amylase. If it is safe, it can be used without particular limitation.
- Aspergillus tamari AOK 43 (Akita Imano Co., Ltd.) can be preferably used as such a bacterium that may use a commercially available strain.
- AOK 210 strain, AOK 43 strain, AOK N4586 strain or AOK B650 strain mutant may also be used. Mutants are the same acidic as AOK 210 strain, AOK 43 strain, AOK N4586 strain or AOK B650 strain from strains obtained by natural mutation of these strains or by mutation treatment with chemical mutagens or ultraviolet rays, etc.
- a strain having the ability to produce an enzyme can be selected and obtained.
- the size is 50-60mm in diameter, the color changes from yellow to green, and the color changes to brownish over time.
- the mycelium is inconspicuous and the back is colorless.
- the ability to produce an acidic enzyme refers to producing an acidic enzyme to the extent that acidic enzyme activity can be detected in a culture obtained by culturing bacterial cells. Detection of the acidic enzyme activity in the culture can be performed according to a conventional method.
- Aspergillus soya, Aspergillus tamari, Aspergillus 'foetidas, Aspergillus'-Gar and Aspergillus' oryzae used in the present invention have protozoal activity against coccidium causing intestinal infections in animals. I like it.
- the animal feed additive of the present invention can contain one kind of strain among the above-mentioned fungal species, or can contain two or more strains in combination. Among these, it is preferable to contain at least one of Aspergillus soya and Aspergillus oryzae.
- the animal feed additive of the present invention includes the aforementioned Aspergillus soja and Aspergillus.
- the animal feed additive of the present invention may be added to the feed component as it is and mixed.
- a powdered or solid animal feed additive In order to facilitate mixing, it can be used in liquid or gel form.
- water, soybean oil, rapeseed oil, vegetable oil such as corn oil, liquid animal oil, water-soluble polymer compounds such as polybulal alcohol, polyvinylpyrrolidone, and polyacrylic acid can be used as the liquid carrier.
- water-soluble polysaccharides such as alginic acid, sodium alginate, xanthan gum, sodium caseinate, gum arabic, guar gum, tamarind seed polysaccharide, etc. preferable.
- an organic acid can be added to make the liquid viable agent acidic.
- Example 9 A. oryzaelK—05074 100 5430 Example 1 0 A. oryzaelK—05074 4208 51280 150 6120 Comparative Example 3 A. kawachii AOK 1006s 100 5120 Comparative Example 4 A. kawachii AOK 1006s 74 8316 150 5340 Comparative Example 5 A. oryzaelK—05074 (acidic enzyme removal) 10 ⁇ 2000 150 5390 Control group 1 ⁇ ⁇ 150 4960
- the acid-resistant ⁇ -amylase activity of the culture obtained by culturing Aspergillus olise IK-05074 is the acid-resistant enzyme activity of the culture obtained by culturing Aspergillus strain. About 57 times. The sum of acidic protease activity and acidic carboxypeptidase activity was also about 6 times. From this, it can be seen that the strain 05074 has an excellent ability to produce acid amylase, acid protease and acid carboxypeptidase, and in particular, has an excellent ability to produce acid amylase.
- the administration test to the chicken chick of the dry solid culture obtained above was conducted. Solid culture above The product was mixed with the feed at a concentration of 50 ppm and lOOppm with respect to the total mass of the feed (pre- and post-SD broiler product, manufactured by Nippon Compound Feed Co., Ltd.) to give Examples 11-16. In addition, brown rice that had been sterilized by autoclaving and dried without adding bacteria was mixed with feed at a concentration of lOOppm to serve as a control. In the administration test, 10 chicks were grouped and fed to the chicken chicks one week after hatching with the above-mentioned feed freely for 35 days. Table 3 shows the average weight of chicken chicks in each group on day 42 after hatching.
- the acid-resistant a-amylase activity of the culture obtained from brown rice as a solid medium component was about 1.5 times that of the culture obtained from soybean and barley as a solid medium component. It was obviously strong. This shows that when brown rice is used as a solid medium component, the production capacity of acid amylase increases.
- the body weights of the chicken chicks of the groups of Examples 11 to 16 to which the feed containing the animal feed additive of the present invention was administered were all higher than the body weight of the chicken chicks in the control group.
- the feed of the present invention containing an animal feed additive produced using brown rice as a solid medium component is excellent in promoting the increase in body weight.
- Salmonella enteritidis was aerobically cultured at 37 ° C for 24 hours in a standard agar medium. Colonies that grew on the plate were scraped off and suspended in sterile physiological saline. 1L Prepare 500 ml of brain heart infusion bouillon Nissui in an Erlenmeyer flask and sterilize by autoclaving so that the final concentration of SE is approximately 1.0 X 10 4 to 1.0 X 10 5 CFU / ml. It was thrown into.
- the collected culture solution was diluted 10-fold with sterile physiological saline, and 0.1 ml of each diluted solution was added to yolk-added CW agar medium (Nissui Pharmaceutical Co., Ltd.) And anaerobic culture at 37 ° C. for 24 hours using an anero-pack kenki, and the characteristic colonies developed were counted.
- Viable counts of SE and CP were measured on the 0th, 3rd, and 7th days after the start of the test. At the same time, the oxalic acid concentration was quantified.
- the oxalic acid content was below the detection limit.
- the oxalic acid content was below the detection limit.
- Table 14 shows the viable count of EC
- Table 15 shows the viable count of SA.
- Example 36 As shown in Example 36, when co-cultured with IK-05074 strain, the viable count of SA became below the detection limit from the third day of the test, and the solid culture of AOK 1006s strain shown in Comparative Example 13 The antibacterial activity against SA was clearly higher than The control group showed an increase in the number of bacteria after the test and showed 3.7 ⁇ 10 8 CFUZml on the third day.
- Examples 37 to 40 were prepared by mixing ground solid cultures of AOK N4586 strain and AOK B650 strain so as to have lOOppm.
- a group of 12 chicken chicks hatched from broiler breeder (brand: chunky) -derived eggs were fed the feed of Examples 37-40 for 14 days.
- a feed prepared by mixing the ground solid culture of A OK 1006s strain so as to be lOOppm was used as Comparative Example 14.
- the test was carried out in the same manner using a feed mixed with lOOppm of lactose instead of the koji mold culture as a control group.
- 1.8 x 10 5 CFU of Salmonella enteritidis (SE) per dog was orally administered.
- SE Salmonella enteritidis
- a strain isolated from the cecal contents of chickens that died on the farm of a poultry farmer in Gunma Prefecture was used.
- feces were collected by wiping the caecal contents and the total excretory cavity with a cotton swab.
- the cecal contents lg was diluted 10-fold with sterile phosphate buffered saline and mixed well to obtain a sample stock solution.
- the sample stock solution was serially diluted 10 times with sterile physiological saline to obtain a serially diluted solution.
- the sample stock solution and serial dilutions are smeared with 0.1 ml each of SS agar plate “-Susi” (manufactured by Nissui Pharmaceutical Co., Ltd.) and brilliant green agar plate medium (manufactured by Difco Laboratories) at 37 ° C. And the number of colonies of typical SE grown on each plate medium was measured.
- Infection index logarithm of the logarithm of viable SE in the cecal contents of each individual (log CFUZg average)
- Defensive index Infection index in the control zone Z Infection index in each test zone
- LIM agar medium “-Susi” manufactured by Nissui Pharmaceutical Co., Ltd.
- SIM agar medium and TSI agar medium is inoculated from the colony and cultured at 37 ° C for 24 hours to confirm the properties. went.
- Example 41 A chicken chick feed obtained by mixing the ground solid culture of IK-05074 obtained in (a) to lOOppm was designated as Example 41, and the ground solid culture of AOK 1006s was designated lOOppm.
- the feed mixed in such a manner was used as Comparative Example 15, and the feed mixed with lOOppm of lactose instead of the koji mold culture was used as a control group, and chicken chicks were bred using these feeds, and the SE attack test was conducted.
- the test method is 2.
- Table 17 shows the same results as above except that SE of OX 10 5 CFU was orally administered.
- Chicken chick feed (SD broiler for the first term, manufactured by Nippon Compound Feed Co., Ltd., feed containing no antibacterial substances), with respect to the total mass, AOK 210 and AOK 43 obtained in (2) l) AOK N4586
- Examples 42-45 were feeds prepared by mixing the pulverized solid culture of the strain and AOK B650 strain so as to have an lOOppm.
- a group of 12 chicken chicks hatched from a broiler chicken (brand: chunky) -derived eggs were fed the diets of Examples 42-45 for 14 days.
- Comparative Example 16 was a feed in which the ground solid culture of A OK 1006s strain was mixed so as to have an lOOppm.
- the test was carried out in the same manner using a feed mixed with lOOppm of lactose instead of the koji mold culture as a control group.
- a feed mixed with lOOppm of lactose instead of the koji mold culture as a control group.
- 1.1 ⁇ 10 9 CFU of Clostridium perfringens (CP) was orally administered per bird.
- CP was isolated from the cecal contents of chickens that died on the farm of a poultry farmer in Gunma Prefecture. Feces were collected by wiping the contents of the cecum and the total excretory cavity with a cotton swab at 14 days of age.
- the fungus was picked from the colony, inoculated into egg yolk-added CW agar medium (manufactured by Nissui Pharmaceutical Co., Ltd.), and the properties were confirmed by aerobic and anaerobic culture at 35 ° C for 24-48 hours.
- the number of viable CP per cecal content lg was calculated by multiplying the number of colonies recognized as CP from this by the dilution factor of the diluent. Based on this result, the infection index and the control index were calculated in the same manner as described above.
- the properties of CP were confirmed by qualitative culture for each individual by the following method. Specifically, the feces adhering to the swab was suspended in 10 ml of sterilized phosphate buffered saline to prepare a sample stock solution, and then 0.1 ml each was applied to a clostridia medium (Nissui Pharmaceutical Co., Ltd.). It was sprayed and anaerobically cultivated at 35 ° C for 24 hours using an aneropack, and the presence or absence of black colonies grown on each plate medium was determined.
- a clostridia medium Nasui Pharmaceutical Co., Ltd.
- the culture containing the acid enzyme produced by Aspergillus' soya, Aspergillus tamari, Aspergillus' foetidas, and Aspergillus' niger of the present invention has an effect of preventing infection by CP.
- Example 46 A chicken chick feed obtained by mixing the ground solid culture of IK-05074 obtained in (a) to lOOppm was designated as Example 46, and the ground solid culture of AOK 1006s was defined as lOOppm.
- the feed mixed in such a manner was used as Comparative Example 17, and the feed mixed with lOOppm of lactose instead of the koji mold culture was used as a control group, and chicken chicks were bred using these feeds, and a CP attack test was conducted.
- the test method is the same as above except that 1.5 X 10 9 CFU of CP was orally administered. The results are shown in Table 19.
- the contents of the small intestine were collected, and the number of viable EC in the small intestine contents was measured by the following method.
- the lg of small intestine was diluted 10-fold with sterile phosphate buffered saline and mixed well to prepare a sample stock solution.
- the sample stock solution was serially diluted 10 times with sterile physiological saline to obtain a serially diluted solution.
- the number of viable EC per lg of small intestine contents was calculated by multiplying the number of colonies recognized as EC by the dilution factor of the diluent. Based on this result, the infection index and the defense index were calculated in the same manner as described above.
- Example 51 is a calf mixed feed prepared by mixing IK-05074 crushed solid culture to lOOppm
- Comparative Example 19 is a feed mixed with AOK 1006s crushed solid culture to lOOppm.
- a feed containing lOOppm of lactose instead of the koji mold culture was used as a control plot, and calves were raised using these feeds and subjected to an EC challenge test.
- the test method is the same as the EC challenge test except that 1.5 X 10 6 CFU of EC was orally administered. The results are shown in Table 21.
- the calf to which the feed containing the IK-05074 strain of Example 51 was administered had a mortality rate of 0%. Also, the EC infection index of small intestine contents was low. The calf to which the diet containing the AOK 1006s strain of Comparative Example 19 was administered had a mortality rate of 13%. In addition, the number of viable ECs did not change much compared to the control group. From this, it was shown that the culture containing the acid enzyme produced by Aspergillus oryzae of the present invention has an effect of preventing infection by EC.
- Piglet feed SD piglet artificial milk for the first period, manufactured by Japan Formula Feed Co., Ltd., calorie feed without antibacterial substances
- AOK 210 strain obtained in (a) AOK 43
- Examples 52-55 were prepared by mixing pulverized solid cultures of the strains AOK N4586 and AOK B650 so as to have lOOppm.
- a feed prepared by mixing lOOppm of the ground solid culture of the AOK1006s strain was designated as Comparative Example 20.
- the test was conducted in the same manner using a feed mixed with lOOppm of lactose instead of the koji mold culture as a control group.
- 2.3 X 10 5 CFU per head were orally infected with Escherichia coli.
- the animals were raised to 54 days of age, and the mortality rate of piglets in each group was calculated.
- the contents of the small intestine were collected, the number of viable EC in the small intestine contents was measured, and the infection index and the defense index were calculated.
- the piglets administered with feed containing AOK 210 strain, AOK 43 strain, AOK N4586 strain and AOK B650 strain of Examples 52-55 had a mortality rate of about 20-30%. Compared to the mortality rate of the group that received the feed, it was small. In addition, the EC infection index of the small intestine contents is low. Particularly, in Example 52, a high protection index was obtained. The viable count of edema disease bacteria was almost unchanged compared to the control group. This shows that cultures containing acid enzymes produced by Aspergillus 'sor, Aspergillus' Tamari, Aspergillus 'Foretidas, and Aspergillus' -Gar of the present invention have an effect of preventing edema disease. It was.
- Example 56 Feed for piglets prepared by mixing the IK-05074 strain solid culture obtained in (a) to lOOppm was designated as Example 56, and the ground solid culture of AOK 1006s strain was defined as lOOppm.
- the mixed feed was used as Comparative Example 21, the feed containing lOOppm of lactose instead of the koji mold culture was used as a control group, and piglets were bred using these feeds and the edema disease test was conducted.
- the test method is the same as the above-mentioned edema disease challenge test except that 1.8 x 10 5 CFU of edema disease was orally administered.
- the piglet administered the diet containing the IK-05074 strain of Example 56 had a mortality rate of about 20%, which was smaller than the mortality rate of the group administered the diet of Comparative Example 21. .
- the EC infection index of small intestine contents was low.
- the viable count of edema disease bacteria was almost unchanged compared to the control group. From this, it was shown that the culture containing the acid enzyme produced by Aspergillus oryzae of the present invention has an effect of preventing edema disease.
- a petri dish charged with 50 mg of the ground solid culture of AOK1006s strain was used as Comparative Example 22, and no koji mold culture was added!
- Each petri dish was shaken (150 rpm) at 37 ° C. Seven days later, the number of oocysts was measured under a stereomicroscope and the state of cell wall deformation and lysis was observed to calculate the oocyst reduction rate and lysis denaturation rate.
- Bovine diarrheal stool naturally infected with Eimeria zuernii was collected, and the oocysts were separated under a stereomicroscope and washed with physiological saline. In a petri dish with a diameter of 9 cm, 5 ml of physiological saline was placed, and about 2000 washed oocysts were added to make a Zml.
- the ground solid cultures of AOK 210 strain, AOK 43 strain, AOK N4586 strain, and AOK B650 strain obtained in (a) were added in an amount of 50 mg per shear, to give Examples 61 to 64, respectively.
- Example 65 the solid culture of the IK-05074 strain clearly reduced the number of oocysts of E. tenella compared to the solid culture of the AOK 1006s strain shown in Comparative Example 24, and the ! / Oocyst dissolution-modifying activity.
- Example 66 the solid culture of ⁇ 05074 strain clearly reduced the number of oocysts of E. zuernii compared to the solid culture of ⁇ 1006s strain shown in Comparative Example 25, and the It showed oocyst dissolving activity.
- the animal feed additive containing the Aspergillus spp. Of the present invention and the culture containing the acidic enzyme produced by the fungus With the feed and ingesting the animal, nutrient absorption is promoted and feed efficiency is improved. Goes up. In addition, the balance of intestinal flora is improved by increasing the concentration of Aspergillus spp. In the intestines of animals. Furthermore, it suppresses the growth of the pathogenic bacterium Kokushijimu and prevents' improves intestinal infections in animals.
- the feed of the present invention can be suitably used for breeding livestock such as chickens, pigs and cows.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0616153-7A BRPI0616153A2 (pt) | 2005-09-20 | 2006-08-01 | aditivo para raÇço animal, raÇço, e, mÉtodo de fabricaÇço de uma raÇço |
US12/067,050 US20090155417A1 (en) | 2005-09-20 | 2006-08-01 | Additive for animal feed |
EP06782089A EP1935253A4 (en) | 2005-09-20 | 2006-08-01 | ADDITIVE TO ANIMAL FEED |
Applications Claiming Priority (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005272049 | 2005-09-20 | ||
JP2005-272049 | 2005-09-20 | ||
JP2006034953 | 2006-02-13 | ||
JP2006-034953 | 2006-02-13 | ||
JP2006-042138 | 2006-02-20 | ||
JP2006042138 | 2006-02-20 | ||
JP2006113092 | 2006-04-17 | ||
JP2006-113092 | 2006-04-17 | ||
JP2006132793 | 2006-05-11 | ||
JP2006-132793 | 2006-05-11 | ||
JP2006-193915 | 2006-07-14 | ||
JP2006-193920 | 2006-07-14 | ||
JP2006193915A JP5025177B2 (ja) | 2006-02-20 | 2006-07-14 | 動物用飼料添加剤 |
JP2006193920A JP5075369B2 (ja) | 2005-09-20 | 2006-07-14 | 動物用飼料添加剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007034627A1 true WO2007034627A1 (ja) | 2007-03-29 |
Family
ID=37888682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/315211 WO2007034627A1 (ja) | 2005-09-20 | 2006-08-01 | 動物用飼料添加剤 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090155417A1 (ja) |
EP (1) | EP1935253A4 (ja) |
KR (1) | KR20080050506A (ja) |
BR (1) | BRPI0616153A2 (ja) |
TW (1) | TW200806190A (ja) |
WO (1) | WO2007034627A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018056271A1 (ja) * | 2016-09-20 | 2018-03-29 | 興人ライフサイエンス株式会社 | 酵母細胞壁を用いた麹菌培養で誘導される抗菌組成物 |
WO2023286534A1 (ja) * | 2021-07-14 | 2023-01-19 | 天野エンザイム株式会社 | 腸内菌叢改善剤 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101284539B1 (ko) * | 2011-01-13 | 2013-07-11 | (주)진바이오텍 | 비전분성 다당류 분해용 복합 효소 조성물 및 이의 제조방법 |
WO2016020911A1 (en) * | 2014-08-06 | 2016-02-11 | Gadot Biochemical Industries Ltd. | Use of biomass from citric acid or gluconic acid production for preventing, ameliorating or treating bowel diseases |
KR20160023278A (ko) | 2014-08-22 | 2016-03-03 | 주식회사 자연제국 | 쌀 누룩을 유효성분으로 하는 사료첨가제의 제조방법 |
US11123410B2 (en) | 2016-02-18 | 2021-09-21 | Amanzo Enzyme Inc. | Intestinal flora improvement agent |
DK3417872T3 (da) | 2016-02-18 | 2024-02-19 | Amano Enzyme Inc | Middel til forbedring af tarmfloraen |
BR112020018294A2 (pt) * | 2018-03-09 | 2020-12-29 | Danisco Us Inc. | Glucoamilases e métodos de uso dos mesmos |
BE1028700B1 (nl) * | 2020-10-13 | 2022-05-16 | Poulpharm Bvba | Werkwijze voor het testen van de efficiëntie van anti-parasitaire (coccidiose) middelen bij pluimvee en konijnen |
KR102370009B1 (ko) * | 2021-06-11 | 2022-03-04 | 이명수 | 반려견 사료용 조성물 제조방법 및 이에 의해 제조된 반려견 사료용 조성물 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5369178A (en) * | 1977-12-05 | 1978-06-20 | Ataka Takashi | Method for producing livestockkfarming feed using shells and stalks of grain like hull |
JPH04183361A (ja) * | 1990-11-15 | 1992-06-30 | Gunze Ltd | 養殖魚用飼料 |
JPH07327666A (ja) * | 1994-06-08 | 1995-12-19 | Nippon Suisan Kaisha Ltd | チオールプロテアーゼ阻害物質高生産能を有する微生物、その微生物を利用したその物質の製造法、その物質を用いた食品の製造法、ならびにその物質からなる品質改良剤 |
JPH1175709A (ja) * | 1997-09-03 | 1999-03-23 | Okabe Sangyo Kk | 混合飼料 |
JP2002238466A (ja) * | 2001-01-31 | 2002-08-27 | Iji Biosystem:Kk | 飼料添加物 |
JP2004189672A (ja) * | 2002-12-11 | 2004-07-08 | Gen Corp:Kk | 抗下痢症組成物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3288683A (en) * | 1963-11-07 | 1966-11-29 | Taisho Pharmaceutical Co Ltd | Production of acid-stable proteolytic and amyloytic enzyme |
JPS5040374A (ja) * | 1973-08-27 | 1975-04-14 | ||
CA1067334A (en) * | 1976-12-22 | 1979-12-04 | Agrimel Limited | Methionine hydroxy analog-containing feed for lactating cows |
JPS5814180B2 (ja) * | 1980-07-17 | 1983-03-17 | 日本醗酵工業株式会社 | 飼料の製造方法 |
CA2222682A1 (en) * | 1995-05-31 | 1996-12-05 | Medzyme N.V. | Composition to improve digestibility and utilisation of nutrients |
JP2002262793A (ja) * | 2001-03-13 | 2002-09-17 | Taketo Kanehiro | 発芽玄米発酵水飴の製法及びその製品 |
US20040115779A1 (en) * | 2002-03-19 | 2004-06-17 | Olsen Hans Sejr | Fermentation process |
US20040156974A1 (en) * | 2003-02-10 | 2004-08-12 | Senya Yamanaka | Method of making amazake |
JP2004248526A (ja) * | 2003-02-18 | 2004-09-09 | Fuyuki Mitsuyama | 医食兼用物 |
-
2006
- 2006-08-01 KR KR1020087009416A patent/KR20080050506A/ko not_active Application Discontinuation
- 2006-08-01 BR BRPI0616153-7A patent/BRPI0616153A2/pt not_active IP Right Cessation
- 2006-08-01 US US12/067,050 patent/US20090155417A1/en not_active Abandoned
- 2006-08-01 EP EP06782089A patent/EP1935253A4/en not_active Withdrawn
- 2006-08-01 WO PCT/JP2006/315211 patent/WO2007034627A1/ja active Application Filing
- 2006-09-19 TW TW095134646A patent/TW200806190A/zh unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5369178A (en) * | 1977-12-05 | 1978-06-20 | Ataka Takashi | Method for producing livestockkfarming feed using shells and stalks of grain like hull |
JPH04183361A (ja) * | 1990-11-15 | 1992-06-30 | Gunze Ltd | 養殖魚用飼料 |
JPH07327666A (ja) * | 1994-06-08 | 1995-12-19 | Nippon Suisan Kaisha Ltd | チオールプロテアーゼ阻害物質高生産能を有する微生物、その微生物を利用したその物質の製造法、その物質を用いた食品の製造法、ならびにその物質からなる品質改良剤 |
JPH1175709A (ja) * | 1997-09-03 | 1999-03-23 | Okabe Sangyo Kk | 混合飼料 |
JP2002238466A (ja) * | 2001-01-31 | 2002-08-27 | Iji Biosystem:Kk | 飼料添加物 |
JP2004189672A (ja) * | 2002-12-11 | 2004-07-08 | Gen Corp:Kk | 抗下痢症組成物 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1935253A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018056271A1 (ja) * | 2016-09-20 | 2018-03-29 | 興人ライフサイエンス株式会社 | 酵母細胞壁を用いた麹菌培養で誘導される抗菌組成物 |
JPWO2018056271A1 (ja) * | 2016-09-20 | 2019-07-04 | 興人ライフサイエンス株式会社 | 酵母細胞壁を用いた麹菌培養で誘導される抗菌組成物 |
WO2023286534A1 (ja) * | 2021-07-14 | 2023-01-19 | 天野エンザイム株式会社 | 腸内菌叢改善剤 |
Also Published As
Publication number | Publication date |
---|---|
BRPI0616153A2 (pt) | 2013-02-19 |
EP1935253A4 (en) | 2009-09-02 |
TW200806190A (en) | 2008-02-01 |
US20090155417A1 (en) | 2009-06-18 |
EP1935253A1 (en) | 2008-06-25 |
KR20080050506A (ko) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007034627A1 (ja) | 動物用飼料添加剤 | |
US9833485B2 (en) | Lactobacillus plantarum capsule for poultry and use thereof | |
JP5872104B2 (ja) | 新たなバチルス・サブチルス{novelbacillussubtilis} | |
JPWO2008023580A1 (ja) | 動物用飼料添加剤 | |
JP5998273B2 (ja) | 新たなバチルス・サブチルス{novelbacillussubtilis} | |
CN110787247B (zh) | 一种防治畜禽腹泻的中药微生态制剂及其制备方法 | |
JP6324536B2 (ja) | 新たなバクテリオファージ及びこれを含む組成物 | |
WO2007058027A1 (ja) | バチルス・チューリンゲンシスを含む有害菌の防除剤 | |
JP5025177B2 (ja) | 動物用飼料添加剤 | |
KR101230813B1 (ko) | 사프로레그니아 속 미생물에 대한 생물학적 방제용 프로바이오틱스 | |
KR101702499B1 (ko) | 신규한 유산균, 진균 및 세균을 포함하는 사료첨가용 조성물 | |
JP5499231B2 (ja) | ラクトバチルス・プランタラムを含有する動物用飼料組成物、該組成物を含有する動物用配合飼料及び前記ラクトバチルス・プランタラムを動物腸管内で維持又は増殖させる方法 | |
KR101427187B1 (ko) | 미생물 생균제를 유효성분으로 함유하는 친환경 미생물 제제 및 이의 제조방법 | |
KR20210053637A (ko) | 케피어 유래 프로바이오틱 효모 클루이베로미세스 막시아누스 a5 및 이의 용도 | |
JP2010051247A (ja) | 病原細菌ならびに真菌に対して抗菌作用を示すバチルス・アミロリケファシエンスを有効成分とする生物的防除剤 | |
JP2010136668A (ja) | 新規シュウドモナス属細菌 | |
KR100951273B1 (ko) | 가축설사 억제제로써 죽엽추출물을 함유하는 미생물활성액 사료첨가제 제조방법 | |
KR20230125654A (ko) | 신규한 페디오코커스 펜토사세우스 균주 및 이를 포함하는 돼지 설사증 예방 또는 개선용 조성물 | |
JP5075369B2 (ja) | 動物用飼料添加剤 | |
JP2007244372A (ja) | バチルス・チューリンゲンシスを含む動物の腸内感染症予防・治療用の飼料添加剤 | |
JP2007159563A (ja) | バチルス・チューリンゲンシスを含む飼料添加剤 | |
JP5970483B2 (ja) | 胞子欠損B.テクサスポルス(B.texasporus)細胞、及び効率的且つ費用対効果の高い不活性化のための方法、及びその使用 | |
CN101312657A (zh) | 动物用饲料添加剂 | |
KR20230062277A (ko) | 탄수화물 분해효소를 생산하는 미츠오켈라 멀타시다 및 이의 용도 | |
KR20230062278A (ko) | 탄수화물 분해효소를 생산하는 라크리미스포라 알지딕실라놀리티카 및 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680043368.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2008/003727 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12067050 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006782089 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087009416 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: PI0616153 Country of ref document: BR Kind code of ref document: A2 Effective date: 20080319 |